Schedule 13D ownership disclosure

ACURA PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 00509L802

Event date: 2016-11-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-004028
Form type
SC 13D/A
Filer
ACURA PHARMACEUTICALS, INC
CIK
CIK 786947
Filed
Jan 25, 2017
Reporting period
Nov 11, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub